Management of idiopathic achalasia: short-term and long-term outcomes.
This article reviews current trends in management of esophageal achalasia, highlighting short-term outcome and cost comparisons of three treatments: botulinum toxin injection, pneumatic dilation, and laparoscopic myotomy. The quality of life resulting from these palliative treatments is also discussed, as are long-term outcomes.
Massey
B T
BT
Dysphagia Institute, Medical College of Wisconsin, Milwaukee 53266, USA. btmassey@mcw.edu
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D001905:Botulinum Toxins / Q000627:therapeutic use; D002404:Catheterization; D003362:Cost-Benefit Analysis; D004931:Esophageal Achalasia / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D017063:Outcome Assessment, Health Care; D011788:Quality of Life
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins